• Title of article

    Lynx1 Prevents Long-Term Potentiation Blockade and Reduction of Neuromodulator Expression Caused by Aβ1-42 and JNK Activation

  • Author/Authors

    Bychkov, M.L Lomonosov Moscow State University, Moscow, Russia , Vasilyeva, N.A Lomonosov Moscow State University, Moscow, Russia , Shulepko, M.A Lomonosov Moscow State University, Moscow, Russia , Balaban, P.M Institute of Higher Nervous Activity and Neurophysiology - Russian Academy of Sciences, Moscow, Russia , Kirpichnikov, M.P Lomonosov Moscow State University, Moscow, Russia , Lyukmanova, E.N Lomonosov Moscow State University, Moscow, Russia

  • Pages
    5
  • From page
    57
  • To page
    61
  • Abstract
    Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels. Many neurodegenera-tive diseases are accompanied by cognitive impairment associated with the dysfunction of nAChRs. The human membrane-tethered prototoxin Lynx1 modulates nAChR function in the brain areas responsible for learning and memory. In this study, we have demonstrated for the first time that the β-amyloid peptide Aβ1-42 decreasesLynx1 mRNA expression in rat primary cortical neurons, and that this decrease is associated with the activation of c-Jun N-terminal kinase (JNK). In addition, we have demonstrated that the Lynx1 expression decrease, as well as the blockade of the long-term potentiation underlying learning and memory, caused by Aβ1-42, may be pre-vented by incubation with a water-soluble Lynx1 analogue. Our findings suggest that the water-soluble Lynx1 analogue may be a promising agent for the improvement of cognitive deficits in neurodegenerative diseases.
  • Keywords
    Ly6/uPAR , β-amyloid peptide , Alzheimer disease , cognitive impairment , nicotinic acetylcholine receptor
  • Journal title
    Acta Naturae
  • Serial Year
    2018
  • Record number

    2616178